Immunity in Perioperative Practice

Immunity in Perioperative Practice - IMPACT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON53931

Enrollment

Registered

2023-02-01

Start date

2023-03-29

Completion date

Unknown

Last updated

2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardia and esophagus cancer) upper gastrointestinal cancer (stomach

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: The participant is... - Assigned to curative treatment for oesophageal cancer, cardia cancer or stomach cancer, including chemoradiotherapy (CROSS) or chemotherapy (FLOT) and surgical resection - Above 18 years of age - Able to understand and speak Dutch or English language

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

Measure	Time frame
- neutrophil subtypes (assessed via immune markers: CD16, CD11b, CD62L, CD10, CD64, CD11b, CD169, CD14, HLA-DR) - complications - physical activity - physical fitness (aerobic capacity, handgrip strength, physical functioning)	—

Secondary

Measure	Time frame
- total leukocytes and neutrophils count - risk for malnutrition - nutritional intake - sleep - perceived immune fitness	—

Countries

Netherlands

Outcome results